Clinical trials
Uterine Cervical Neoplasms trials with no applicable phase and unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
122 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 1 |
| 2012 | 5 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 12 |
| 2017 | 8 |
| 2018 | 9 |
| 2019 | 17 |
| 2020 | 8 |
| 2021 | 14 |
| 2022 | 9 |
| 2023 | 13 |
| 2024 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 122 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tata Memorial Hospital | 5 |
| Asan Medical Center | 3 |
| Charite University, Berlin, Germany | 3 |
| National Taiwan University Hospital | 3 |
| Chen Chunlin | 2 |
| Chongqing University Cancer Hospital | 2 |
| Karolinska Institutet | 2 |
| National Cancer Center, Korea | 2 |
| National Institute of Cancerología | 2 |
| Newish Technology (Beijing) Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 122 |
| Endometrial Neoplasms | 14 |
| Papillomavirus Infections | 10 |
| Ovarian Neoplasms | 8 |
| Uterine Cervical Dysplasia | 8 |
| Uterine Neoplasms | 7 |
| Vulvar Neoplasms | 5 |
| Breast Neoplasms | 4 |
| Neoplasms | 4 |
| Vaginal Neoplasms | 4 |
Trials
Showing 1 to 25 of 122. Each trial links to its page on Pharma Observatory.
22 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.